Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Thyroid Carcinoma, Anaplastic 9Thyroid Neoplasms 4Thyroid Cancer, Papillary 4Neoplasms 3Multiple Myeloma 2Glioma 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma, Follicular 2Thyroid cancer, follicular 1Thyroid cancer, Hurthle cell 1Ovarian Neoplasms 1Nonseminomatous germ cell tumor 1Neoplasms by Site 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation 1Melanoma 1Lymphoproliferative Disorders 1Leukemia, Hairy Cell 1Laryngeal Neoplasms 1Histiocytosis, Langerhans-Cell 1Hematologic Neoplasms 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Erdheim-Chester Disease 1Differentiated Thyroid Cancer (DTC) 1Colorectal Neoplasms 1Biliary Tract Neoplasms 1Advanced Thyroid Cancer Patients Who Received Target Therapy 1Adenoma, Oxyphilic 1

Interventions

trametinib 1dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoproliferative Disorders × dabrafenib × Endocrine × Clear all
NCT07440290 2026-02-27

DETERMINE

Cancer Research UK

Phase 2/3 Not yet recruiting
30 enrolled
CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡